Perspectives

Conversations, ideas, and news at the interface of technology and biology.

Endpoints News

Dimension nabs $500M second fund for 'still contrary' intersection of bio and machine learning

December 9, 2024
Read Article

Blog

Article

A generational leap in regenerative medicine

Nan Li
Founder & Managing Partner
Read Article

Article

AI foundation models to predict and reprogram interactions between biochemical molecules

Zavain Dar
Founder & Managing Partner
Read Article

Article

Geometric deep learning for rational design of molecular glues

Zavain Dar
Founder & Managing Partner
Read Article

Article

Automating chemotype evolution for rapid drug discovery

Adam Goulburn, PhD
Founder & Managing Partner
Read Article

Article

AI-ready data does not exist without lab automation

Nan Li
Founder & Managing Partner
Read Article

[Type of Content]

“This is a pull quote, used to highlight a significant passage of the article. add more line”

[Author Name]
[Author Title]
Read Article
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog
Dimension
Investing In Aspect Biosystems
Read Article
January 8, 2025
Letter
Dimension
Announcing Dimension II
December 9, 2024
Blog
Dimension
Investing in Chai Discovery
Read Article
September 9, 2024
Blog
Dimension
Investing in Monte Rosa Therapeutics
Read Article
May 21, 2024
Blog
Dimension
Investing in Kimia Therapeutics
Read Article
December 19, 2023
Blog
Dimension
Investing in Automata
Read Article
October 3, 2023
Blog
Dimension
Welcoming Eric Dai to the Investment Team
Read Article
September 7, 2023
Blog
Dimension
Announcing Simon Barnett as Research Director
Read Article
June 13, 2023
Video
March 6, 2023
New York Bio
New York Bio Breakfast Series
Watch Video
March 6, 2023
Podcast
March 2, 2023
Homeroom Podcast
Homeroom Podcast : Adam Goulburn
Listen
March 2, 2023
News
October 2, 2023
Endpoints
Dimension leads $40M round for lab automation company Automata Technologies
Read Article
October 2, 2023
Feature
October 26, 2023
The Generalist
The Generalist: Zavain Dar, GP at Dimension on investing at the bleeding edge of technology and life sciences
Read Article
October 26, 2023
News
December 19, 2023
Endpoints
Kimia Therapeutics secures $55M to supercharge co-founder’s platform, create ‘next-generation Carmot’
Read Article
December 19, 2023
Podcast
February 9, 2024
Touching Base
Intellia and Ultragenyx’s Clinical Updates, Novo Holdings’ Catalent Acquisition, and NanoString Bankruptcy; Simon Barnett
Listen
February 9, 2024
News
February 28, 2024
Bio World
Biocom 2024: Developing new AI capabilities (and maybe going faster, too)
Read Article
February 28, 2024
News
April 15, 2024
Stifel
A Conversation with Kimia’s CEO, Stig Hansen
Read Article
April 15, 2024
News
April 18, 2024
GEN Biotechnology
The Difference Is the Data: Drug Discovery's AI Revolution
Read Article
April 18, 2024
News
May 21, 2024
Endpoints News
With a fresh $100M, Monte Rosa CEO details plans to move several molecular glues into the clinic
Read Article
May 21, 2024
News
September 9, 2024
BNN Bloomberg
OpenAI, Thrive Capital Back Six-Month-Old AI Drug Discovery Startup
Read Article
September 9, 2024
News
September 9, 2024
Chai Discovery Team
Introducing Chai-1: Decoding the molecular interactions of life
Read Article
September 9, 2024
News
October 10, 2024
GEN Biotechnology
In biotech, time is money
Read Article
October 10, 2024
Podcast
October 30, 2024
GEN Biotechnology
The State of AI in Drug Discovery
Listen
October 30, 2024
News
December 5, 2024
Timmerman Report
Computational Techniques Are Driving a Tidal Shift in Therapeutic Protein Design
Read Article
December 5, 2024
Video
December 9, 2024
Dimension
This is just the beginning. Make no small plans.
Watch Video
December 9, 2024
News
December 9, 2024
Timmerman Report
Dimension Raises $500M to Seize the Tech Driven Biology Future
Read Article
December 9, 2024
News
December 9, 2024
Axios
VC firm raises $500 million for fund aimed at intersection of tech and life sciences
Read Article
December 9, 2024
News
December 9, 2024
BioPharma Drive
Dimension gets $500M to bankroll biotech’s convergence with tech
Read Article
December 9, 2024
News
December 9, 2024
Bloomberg
VC Firm Dimension Raises $500 Million to Bet on AI and Medicine
Read Article
December 9, 2024
News
December 9, 2024
STAT News
Young biotech venture firm raises $500 million for its second fund
Read Article
December 9, 2024
News
December 9, 2024
TechCrunch
Dimension raises $500M second fund for investing at the intersection tech and life sciences
Read Article
December 9, 2024
News
December 9, 2024
WSJ
Dimension Books $500 Million for Second Life Sciences Venture Fund
Read Article
December 9, 2024
News
December 9, 2024
Fierce Bio
The 2nd Dimension: VC raises $500M fund for entrepreneurs pioneering life sci, tech
Read Article
December 9, 2024
Video
December 16, 2024
Biotech TV
Dimension's Zavain Dar talks about raising a $500M second fund
Watch Video
December 16, 2024
News
December 12, 2024
BioCentury
Techbio VC Dimension upsizes for $500M second fund
Watch Video
December 12, 2024
News
January 8, 2025
Endpoints News
Novo-allied Aspect Biosystems nabs $115M for bioprinted tissue therapies
Read Article
January 8, 2025
News
February 4, 2025
Timmerman Report
Deepseek Shocked Silicon Valley but Its Not Earth Shaking for Biotech
Read Article
February 4, 2025
News
February 21, 2025
Endpoints News
Nvidia-backed Achira debuts, blending AI and physics to model molecules
Read Article
February 21, 2025
News
February 21, 2025
FirstWord Pharma
Nvidia, Dimension back startup building synthetic datasets for AI drug discovery
Read Article
February 21, 2025
News
February 27, 2025
STAT News
New kids on the block: A new generation of VCs ventures into biotech
Read Article
February 27, 2025
News
April 28, 2025
Endpoints News
Can AI replace animal testing? A new biotech launches to find out
Read Article
April 28, 2025
News
May 1, 2025
Endpoints News
Ex-Calico scientist launches Stately Bio with new way to study cells
Read Article
May 1, 2025
News
February 26, 2025
FirstWord Pharma
Sanofi backs Enveda's AI-plus-nature approach to drug discovery
Read Article
February 26, 2025
News
May 6, 2025
TechCrunch
NewLimit, founded by Coinbase CEO Brian Armstrong, raises $130M to develop age-reversing treatments
Read Article
May 6, 2025
News
May 6, 2025
Endpoints News
Brian Armstrong’s NewLimit raises a $130M Series B, laying out road map for anti-aging drugs
Read Article
May 6, 2025
Video
May 6, 2025
Core Memory
The Company Trying to Reprogram Aging
Watch Video
May 6, 2025
News
May 8, 2025
Timmerman Report
NewLimit's Anti-Aging Bounty
Read Article
May 8, 2025
Feature
January 26, 2023
Fortune
Three venture investors weigh in on the future of biotech as they launch a new $350M fund
Read Article
1
January 26, 2023
Feature
January 25, 2023
BioPharma Dive
Three VCs launch Dimension, a new firm with plans to fuel biotech’s ‘digitization’
Read Article
1
January 25, 2023
News
May 16, 2023
Fortune
Coinbase founder Brian Armstrong raises $40 million for NewLimit, a startup that wants to ‘cure aging’
Read Article
1
May 16, 2023
Feature
February 13, 2024
Endpoints News
The Endpoints Slack interview: Zavain Dar on starting a new VC, trusting the process with the 76ers, and Apple's VR future
Read Article
1
February 13, 2024
Feature
January 26, 2023
Wall Street Journal
New VC Firm Dimension Gets $350 Million as Healthcare Venture Fundraising Remains High
Read Article
2
January 26, 2023
Podcast
January 31, 2023
Dead Cat Podcast
Eric Newcomer: A New Dimension
Listen
2
January 31, 2023
Feature
January 25, 2023
Timmerman Report
Dimension Debuts With 350M To Back Startups That Digitize Biology
Read Article
2
January 25, 2023
News
May 16, 2023
TechCrunch
NewLimit, cofounded by Coinbase CEO Brian Armstrong, raises $40M to extend life
Read Article
2
May 16, 2023
News
December 9, 2024
Endpoints News
Dimension nabs $500M second fund for 'still contrary' intersection of bio and machine learning
Read Article
2
December 9, 2024
Feature
January 25, 2023
Fierce Biotech
Creating a new dimension: Biotech VC merging tech and life sciences unveils with $350M
Read Article
3
January 25, 2023
Feature
January 25, 2023
BioSpace
As Tech Giants Fall, Tech-Focused VC Fund Rakes in $350M
Read Article
4
January 25, 2023
Feature
January 25, 2023
Forbes
These Venture Veterans Have Launched A $350 Million Fund Aimed At Digitizing Life Sciences
Read Article
5
January 25, 2023
Feature
January 25, 2023
STAT
Focused exclusively on life sciences, three top investors set out on their own
Read Article
6
January 25, 2023
Feature
January 25, 2023
Endpoints
‘Siloing is just so outdated’: New $350M VC fund aims to digitize life sciences
Read Article
7
January 25, 2023
Sort by published date